secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2024-08-15T23:59:59+00:00
Accession:  0001193125-24-201372
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics stockholders elect all six director nominees and ratify auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- All six director nominees elected: Clowes, van Es-Johansson, Hawkins, Hedrick, Lenk, Petersen. Votes For ranged 1.16M-1.18M.
- Ratification of BDO USA as auditor for FY2024 approved: 2.43M For, 44,854 Against.
- Advisory say-on-pay approved: 1.12M For, 163,917 Against.
- Fourth amendment and restatement of 2020 Stock Incentive Plan approved: 1.10M For, 182,432 Against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312524201372/0001193125-24-201372-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312524201372/d864499d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-201372

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer